KZA kazia therapeutics limited

Ann: Kazia Annual Report to shareholders, page-9

  1. 1,074 Posts.
    lightbulb Created with Sketch. 452
    IMHO, lots of good indicators - numerous key clinical experts involved, multiple pedigree med institutes, multiple indications of support from FDA, great paxalisib early data, good cash, multiple pull (investigator led) studies, invitation to world leading registration study.

    Just waiting on data now.

    GLTA.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.